For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Evelo Biosciences, Inc.

USPTO Granted Patents = 14

EPO Patents = 1

Trademarks = 3

Forward Citations = 61

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Brian Goodman (8 out of 9 patents)

Holly Ponichtera (7 out of 7 patents)

David Arthur Berry (6 out of 84 patents)

4. Shaila Rahman (6 out of 9 patents)

5. Maria Sizova (6 out of 6 patents)

6. Johanne Kaplan (6 out of 17 patents)

7. Andrea Itano (4 out of 4 patents)

8. Taylor A Cormack (4 out of 4 patents)

9. Carolina Baez-Giangreco (3 out of 3 patents)

10. Peter Sandy (3 out of 3 patents)

11. Jacqueline Papkoff (3 out of 3 patents)

12. Humphrey Gardner (3 out of 3 patents)

13. Noubar Boghos Afeyan (3 out of 77 patents)

14. Kritika Ramani (2 out of 2 patents)

15. Baundauna Bose (2 out of 3 patents)

14 patents: Sort by Forward Citations

1. 11672834 - Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome (2023-06-13),

2. 11612622 - Probiotic compositions containing clostridiales for inhibiting inflammation (2023-03-28),

3. 11607432 - Probiotic compositions containing clostridiales for inhibiting inflammation (2023-03-21),

4. 11524037 - Bacterial extracellular vesicles (2022-12-13),

5. 11266700 - Compositions and methods for treating immune disorders using immune modulatingbacteria strains (2022-03-08),

6. 11241461 - Treating cancer using a blautia strain (2022-02-08),

7. 11090341 - Compositions and methods for treating cancer and immune disorders usingbacteria (2021-08-17),

8. 10980845 - Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome (2021-04-20),

9. 10869903 - Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease (2020-12-22),

10. 10792314 - Compositions and methods of treating cancer usingssp. (2020-10-06),

11. 10702561 - Pharmaceutical compositions comprising astrain (2020-07-07),

12. 10576111 - Method of treating cancer usingssp.strain PTA-125097 (2020-03-03),

13. 10493113 - Compositions and methods for treating disease using astrain (2019-12-03),

14. 9603878 - Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease (2017-03-28),

Evelo Biosciences, Inc. is a clinical-stage biotechnology company that focuses on the development of therapies for cancer and autoimmune diseases. They harness the power of the gut-body network, aiming to modulate the immune system safely and effectively. Evelo Biosciences utilizes their proprietary oral biologics platform to create therapies that act on specific cells in the gut, delivering therapeutic effects throughout the body. Through their innovative approach, they strive to improve patients' lives and create a new paradigm in medicine.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

14 Patents

#158 in Cambridge, MA

#1,315 in Massachusetts

#21,607 in US

#40,905 in the World

Cambridge, MA, United States of America

Evelo Biosciences, Inc.

Forward Citations = 61

25 inventors:

Brian Goodman (8 out of 9 patents)

Holly Ponichtera (7 out of 7 patents)

David Arthur Berry (6 out of 84 patents)

4. Shaila Rahman (6 out of 9 patents)

5. Maria Sizova (6 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…